Topics in Oncology Full Course* (20 AMA PRA - Category 1 CME)

This course is in DIGITAL (ONLINE) FORMAT ONLY and provides 20 CME and is consistent with a seminar of up to 10 days.Cardiovascular Complications in Cancer Survivors/Genomic Risk Stratification and High-Sensitivity Imaging in Localized Prostate CancerAudio-Digest Oncology (10/22/25)Cardiovascular Complications in Cancer Survivors - Eric H Yang, MDGenomic Risk Stratification and High-Sensitivity in Localized Prostate Cancer - Tanya B Dorff, MDUltra-Low HER2 Breast Cancer/Metastatic Soft Tissue SarcomaAudio-Digest Oncology (10/3/25)Ultra-Low HER2 Breast Cancer – Rena D. Callahan, MDMetastatic Soft-Tissue Sarcoma: Treatment Updates – Mark Agulnik, MDOrgan Preservation/Lung NodulesAudio-Digest Oncology (9/15/25)Organ Preservation in Patients with Locally Advanced Head and Neck Cancer – Everett E. Vokes, MDLung Nodules: Identification and Course of Action – Gregory C. Kane, MD Small Cell Lung Cancer/Breast Cancer/MelanomaAudio-Digest Oncology (8/26/25)Novel and Emerging Therapies for Small Cell Lung Cancer – Noura Choudhury, MDNovel Therapeutics in Breast Cancer – Nan Chen, MDTILs: Cell Therapy for a Solid Tumor – Dan Olson, MDStem Cell Transplantation in AL Amyloidosis/Immunotherapy in Multiple Myeloma/Maintenance Therapy After Stem Cell TransplantationAudio-Digest Oncology (8/6/25)Role of Stem Cell Transplantation in the Treatment of AL Amyloidosis – Vaishali Sanchorawala, MDNovel Targets for Immunotherapy in Multiple Myeloma – Ben Derman, MDMaintenance Therapy After Allogeneic Hematopoietic Cell Transplantation – Mark Levis, MD, PhD Hodgkin and Non-Hodgkin Lymphoma/Acute Myeloid Leukemia/Myeloproliferative Neoplasms, Myelodysplastic Syndromes, and MyelofibrosisAudio-Digest Oncology (7/18/25)Update on Hodgkin and Non-Hodgkin Lymphoma – Alexandra Rojek, MDUpdate on Acute Myeloid Leukemia – Rafael Madero Marroquín, MDUpdate on Myeloproliferative Neoplasms, Myelodysplastic Syndromes, and Myelofibrosis – Anand Patel, MDMinimal Residual Disease and CT-DNA/Oncofertility/Race and Clinical Outcomes in the Rxponder TrialAudio-Digest Oncology (6/27/25)Minimal Residual Disease and ct-DNA – Daniel G. Stover, MDOncofertility – Natalia C. Llarena, MDRace and Clinical Outcomes in the RxPonder Trial – Yara Abdou, MDManagement of Breast CancerAudio-Digest Oncology (6/2/25)Antibody Drug Conjugates in Advanced HR+/HER2 Breast Cancer and Triple-Negative Breast Cancer – Rebecca Shatsky, MDOmission of Radiation for Early-Stage Breast Cancers – Tim Whelan, MD Melanoma/Hepatocellular Carcinoma/Breast CancerAudio-Digest Oncology (5/14/25)Navigating the Complexities of Advanced Melanoma Treatment – Kathryn Bollin, MDUpdates in Hepatocellular Carcinoma – Nataliya Razumilava, MDInnovations in Breast Cancer Surgery – Eleni Tousimis, MD, MBAOncolytic Immunotherapy/Systemic Therapy for Squamous Cell Carcinoma and Non-Melanoma Skin Cancer/Systemic Workup for High-Risk Cutaneous MalignanciesAudio-Digest Oncology (4/28/25)Oncolytic Immunotherapy: New Insights – Merrick I. Ross, MDSystemic Therapy for Squamous Cell Carcinoma and Non-Melanoma Skin Cancer – Kathryn Bollin, MDSystemic Workup for High-Risk Cutaneous Malignancies – Lisa Fronek, DO    16:8-17